Sernova Biotherapeutics
(TSX) SVA
Sernova Biotherapeutics Financials at a Glance
Market Cap
$64.33M
Revenue (TTM)
$0.00
Net Income (TTM)
$12.38M
EPS (TTM)
$-0.04
P/E Ratio
-4.95
Dividend
$0.00
Beta (Volatility)
0.47 (Low)
Dividend
$0.00
Beta (Volatility)
0.47 (Low)
Price
$0.18
Volume
139,924
Open
$0.17
Price
$0.18
Volume
139,924
Open
$0.17
Previous Close
$0.18
Daily Range
$0.17 - $0.18
52-Week Range
$0.12 - $0.23
Dividend
$0.00
Beta (Volatility)
0.47 (Low)
Price
$0.18
Volume
139,924
Open
$0.17
Previous Close
$0.18
Daily Range
$0.17 - $0.18
52-Week Range
$0.12 - $0.23
SVA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sernova Biotherapeutics
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Jonathan M. N. Rigby, MBA
Website
www.sernova.comHeadquarters
London, ON N6G 4X8, GB
SVA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
50%
Return on Assets
-12%
Earnings Yield
-20.20%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$64.33M
Shares Outstanding
347.73M
Volume
139.92K
Short Interest
0.00%
Avg. Volume
114.46K
Financials (TTM)
Gross Profit
$342.59K
Operating Income
$15.12M
EBITDA
$14.74M
Operating Cash Flow
$10.91M
Capital Expenditure
$3.00
Free Cash Flow
$10.91M
Cash & ST Invst.
$265.00K
Total Debt
$17.28M
Sernova Biotherapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$4.43K
+90.7%
Gross Margin
0.00%
N/A
Market Cap
$64.33M
N/A
Market Cap/Employee
$3.78M
N/A
Employees
17
N/A
Net Income
$2.33M
+59.0%
EBITDA
$2.11M
+61.4%
Quarterly Fundamentals
Net Cash
$16.97M
-2667.4%
Accounts Receivable
$125.59K
-66.4%
Inventory
$0.00
N/A
Long Term Debt
$1.08M
+145.2%
Short Term Debt
$16.47M
+15407.5%
Return on Assets
-12.23%
N/A
Return on Invested Capital
50.18%
N/A
Free Cash Flow
$1.05M
+78.3%
Operating Cash Flow
$1.05M
+78.3%